Report finds Big Pharma is doing more for access to medicine in developing countries
- Details
- Category: Development
The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago, with GlaxoSmithKline still outperforming its peers, but an expanding group of leaders closing the gap.
Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
- Details
- Category: Development
Scientists in the United States have tested all possible pairings of the 100 cancer drugs approved for use in patients in order to discover whether there are any combinations not tried previously that are effective in certain cancers.
The Nobel Prize in Chemistry 2012
- Details
- Category: Development
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2012 to Robert J. Lefkowitz Howard Hughes Medical Institute and Duke University Medical Center, Durham, NC, USA and Brian K. Kobilka Stanford University School of Medicine, Stanford, CA, USA for studies of G-protein-coupled receptors.
The Nobel Prize in Physiology or Medicine 2012
- Details
- Category: Development
The Nobel Assembly at Karolinska Institutet has today decided to award The Nobel Prize in Physiology or Medicine 2012 jointly to John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent.
First-ever treatment for rare childhood aging disease shows improvement in all trial participants
- Details
- Category: Development
Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system,
Ten pharmaceutical companies unite to accelerate development of new medicines
- Details
- Category: Development
Ten leading biopharmaceutical companies have formed a non-profit organization to accelerate the development of new medicines. Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech a member of the Roche Group, and Sanofi launched TransCelerate BioPharma Inc.
Canada needs national approach to protect against drug shortages
- Details
- Category: Development
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Canadian Pharmacists Journal).
More Pharma News ...
- World Health Assembly endorses new plan to increase global access to vaccines
- Got a great idea? Submit yours to Grand Challenges Explorations
- Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations
- GE Healthcare and M+W Group form strategic alliance in vaccines, insulin and biopharmaceuticals
- IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
- Springer Healthcare Announces Agreement With ASCO®
- Unparalleled global progress in HIV response but sustained investment vital